Astrana Health, Inc. announced on January 21, 2025, that it repurchased 300,000 shares of its common stock on January 17, 2025. The aggregate purchase price for these shares was $10.551 million, based on a price of $35.17 per share.
The shares were acquired from Allied Physicians of California (APC), a long-standing stockholder and a consolidated affiliate of the company. This share repurchase was approved by Astrana's Board of Directors and the Audit Committee of the Board of Directors.
President and CEO Brandon K. Sim stated that the repurchase reflects management's and the Board's confidence in Astrana Health's performance. The company remains committed to strategic capital deployment practices, prioritizing long-term growth, including opportunistic share repurchases.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.